STAT

MARCH 18, 2024

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

Biosimilars 363

Biosimilars Drug Pricing Documentation Pharmaceutical Companies 363

STAT

NOVEMBER 1, 2023

A pharmaceutical company and its chief executive — who once defended Martin Shkreli for raising drug prices to controversial heights — agreed to pay up to $50 million to settle allegations of purposely underpaying Medicaid rebates.

Drug Pricing 333

Drug Pricing Documentation Pharmaceutical Companies Pharmaceutical Companies 333

STAT

JANUARY 26, 2023

In her latest bid to address prescription drug prices, U.S. Federal Trade Commission to “closely scrutinize” two pending pharmaceutical company mergers over concerns that “rampant consolidation” will drive up costs for consumers. Elizabeth Warren (D-Mass.) is urging the U.S.

Drug Pricing 253

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 253

STAT

MARCH 22, 2023

In the face of rising drug prices, health plan sponsors have quietly used a clever, but questionable tactic over the past few years to deflect costs. And now, some pharmaceutical companies are pushing back.

Drug Pricing 243

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 243

STAT

MARCH 28, 2023

drug crisis has accelerated, the pharmaceutical industry has jumped into action — particularly when it comes to naloxone, the drug used to reverse opioid overdoses , STAT reports. … As the U.S.

Drug Pricing 246

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 246

STAT

JULY 6, 2023

But they’ve intensified over the past three months as Congress scrutinizes PBMs’ role in shaping high drug prices. On one side is the Pharmaceutical Care Management Association, the trade association representing PBMs, which argues that pharmaceutical companies are responsible for high drug prices.

Drug Pricing 244

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 244

STAT

FEBRUARY 15, 2024

For several years , some of the world’s largest pharmaceutical companies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.

Hospitals 334

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 334

Pharmaceutical Technology

NOVEMBER 22, 2023

A US senate committee scheduled a hearing on prescription drug pricing with major pharmaceutical companies.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 98

STAT

AUGUST 9, 2024

Chamber of Commerce lawsuit challenging the Medicare Drug Price Negotiation Program established through the Inflation Reduction Act, with a judge finding that several plaintiffs in the suit lacked standing , STAT reports. Or you could simply hide indoors and binge-watch something on the telly. Well, whatever you do, have a grand time.

Drug Pricing 255

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 255

STAT

OCTOBER 7, 2022

… The drug-pricing law will still penalize pharmaceutical companies if they hike prices on medicines for patients who have private insurance, STAT says. The penalties may factor into decisions for pricing medicines as the new law begins to take effect. Enjoy, and see you soon.

Drug Pricing 229

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 229

STAT

NOVEMBER 19, 2024

Although more pharmaceutical companies are tailoring their business models to focus on low-income countries, a new analysis finds that overall industry efforts remain limited and patient access continues to suffer as a result.

Pharmaceutical Companies 326

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 326

STAT

JULY 22, 2024

The report , which was released in March but received little if any public attention, examined drug spending between 2016 and 2021 within the health plan that covers more than 200,000 unionized mail carriers and post office workers, as well as retirees.

Pharmaceutical Companies 363

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 363

STAT

SEPTEMBER 24, 2024

In the latest slap at a pharmaceutical company by a local government, the city of Baltimore has filed a lawsuit accusing Biogen of striking an “unlawful” scheme with the largest pharmacy benefit managers to block generic competition of a best-selling multiple sclerosis treatment.

Pharmaceutical Companies 352

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 352

STAT

DECEMBER 4, 2024

Patent & Trademark Office has withdrawn a controversial proposal that was designed to prevent pharmaceutical companies from abusing the patent system. In an unexpected move, the U.S.

Generic Medicine 294

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 294

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing.

Diabetes 348

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines 348

STAT

MARCH 21, 2024

As more states create dedicated boards to cap the costs of medicines, some drugmakers and their allies are pushing back with a controversial tactic — lobbying for legislation to set exemptions for so-called orphan drugs, which are used to combat rare diseases that afflict relatively small groups of patients.

Pharmaceutical Companies 336

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 336

STAT

OCTOBER 17, 2023

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

Pharmaceutical Companies 354

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 354

STAT

AUGUST 22, 2023

German drugmaker Boehringer Ingelheim is the latest pharmaceutical company to sue the federal government over a law that would allow Medicare to negotiate certain drug prices, Reuters reports.

Vaccines 236

Vaccines Drug Pricing Diabetes Pharmaceutical Companies 236

STAT

FEBRUARY 8, 2024

A road test for fresh pharma CEOs A lot can change in five years — including the leadership of the three major pharmaceutical companies that will be testifying before Sen.   Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Bernie Sanders’ HELP Committee today. Read the rest…

Pharmaceutical Companies 270

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Vaccines 270

STAT

OCTOBER 10, 2024

At the same time, Teva steadily raised the price of its drug by thousands of dollars.

Pharmaceutical Companies 322

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 322

BioPharma Dive

JUNE 15, 2023

Lobbying group PhRMA does not expect any near-term changes to the IRA’s drug pricing provisions, but is attempting to lay groundwork for future changes.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 64

STAT

OCTOBER 2, 2024

In reality, the arrangements actually resemble private-label distribution, but the lawmakers worry these agreements could cause consumers to pay higher prices.

Labelling 311

Labelling Biosimilars Pharmaceutical Companies Pharmaceutical Companies 311

STAT

JUNE 17, 2024

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace. In a bid to prevent the patent system from being abused, the U.S.

Generic Medicine 320

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 320

STAT

SEPTEMBER 19, 2024

Sometimes, a delay is caused by a patent review, so the PTO will compensate a pharmaceutical company by extending the life of the patent by the number of days caused by the delay. Conversely, if a company was slow to respond to requests, the time is subtracted from the patent life.

Pharmaceutical Companies 314

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 314

STAT

JANUARY 6, 2023

The Food and Drug Administration on Friday approved a new Alzheimer’s disease treatment that moderately slows cognitive decline in people with early-stage disease. Read the rest…

Pharmaceutical Companies 246

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 246

STAT

OCTOBER 10, 2024

billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging 297

Packaging Diabetes Pharmaceutical Companies Pharmaceutical Companies 297

STAT

JANUARY 19, 2023

In a bid to blunt competition and address rising drug costs, Sanofi is offering a warranty that will cover the cost for any hospital if a specific medicine fails to work, marking only the second time a major pharmaceutical company has taken such a step.

Hospitals 263

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 263

STAT

DECEMBER 14, 2024

government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceutical company has been threatened with such a step.

Hospitals 211

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 211

The Guardian - Pharmaceutical Industry

JUNE 9, 2024

With the heavy encouragement of pharmaceutical companies, the blame for such shortfalls often falls on the National Institute for Health and Care Excellence (Nice), the public body that advises the NHS on whether medicines represent value for money.

Drug Pricing 81

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 81

STAT

OCTOBER 18, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You

Pharmaceutical Companies 262

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 262

STAT

AUGUST 8, 2023

Amid concerns that the pharmaceutical industry unfairly wins monopolies on medicines, a new analysis finds there has been a whopping 200% increase in patents filed by companies that made few substantive changes to their drugs during a 15-year period. health care system to pay higher prices for medicines for extended periods.

Pharmaceutical Companies 225

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 225

Drug Channels

FEBRUARY 7, 2024

And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures. healthcare expenditures.

Drug Pricing 93

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 93

STAT

DECEMBER 19, 2024

Access to cheaper alternatives and low enrollment prompted the company to remove the medicine — along with the HIV medicines Emtriva, Tybost, and Complera — from its patent assistance program next month, according to an Oct. 8 letter that announced the move and that has not been widely reported.

Pharmaceutical Companies 206

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Drug Development 206

STAT

NOVEMBER 22, 2024

The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceutical company to disclose plans to change the way it will make payments.

Hospitals 288

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 288

Express Pharma

NOVEMBER 28, 2024

Global pharmaceutical companies have played a pivotal role in transforming the healthcare sector in India. Approximately 70 per cent of global pharmaceutical companies are expected to achieve annual growth of over 10 per cent in India over the next five years.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 105

RX Note

APRIL 16, 2023

Why Drug Prices Are Rising? Newly developed drugs can be expensive to produce. During patent exclusivity, prices are set higher to offset the high research and development cost (up to billions of dollars). Pharmaceutical industry also spent a lot of money on marketing.

Drug Pricing 40

Drug Pricing Documentation Pharmaceutical Companies Pharmaceutical Companies 40

STAT

JULY 6, 2023

Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us.

Drug Pricing 192

Drug Pricing Vaccines Diabetes Pharmaceutical Companies 192